Norepinephrine-Transporter-Targeted and DNA-Co-Targeted Theranostic Guanidines

Zbigniew P Kortylewicz1, Donald W Coulter2, Guang Han1,3

  • 1Department of Radiation Oncology, J. Bruce Henriksen Cancer Research Laboratories, University of Nebraska Medical Center, Omaha, Nebraska 68132-6850, United States.

Insights

New theranostic guanidines target neuroblastoma cells, incorporating into DNA and causing tumor regression. This DNA-targeting approach offers a promising new treatment for high-risk neuroblastoma, showing significant tumor retention and regression in preclinical models.

Area of Science:

  • Oncology
  • Radiochemistry
  • Molecular Biology

Background:

  • High-risk neuroblastoma frequently recurs despite intensive therapies.
  • Cellular proliferation is a key indicator of poor prognosis in neuroblastoma.
  • Novel therapeutic strategies are needed to overcome treatment resistance.

Purpose of the Study:

  • To synthesize and characterize novel theranostic guanidines for neuroblastoma.
  • To evaluate the DNA-targeting and therapeutic potential of these agents.
  • To assess the efficacy of guanidine-based radiopharmaceuticals in preclinical neuroblastoma models.

Main Methods:

  • Synthesis and characterization of novel guanidine compounds.
  • Assessment of cellular uptake and DNA incorporation in neuroblastoma cells.
  • In vivo biodistribution and efficacy studies in a mouse neuroblastoma xenograft model.
  • Evaluation of radiotoxicity correlated with DNA uptake and exposure duration.

Main Results:

  • Theranostic guanidines were successfully synthesized and characterized.
  • Active transport of guanidines into neuroblastoma cells was confirmed, with competitive inhibition observed.
  • Radioiodinated guanidines demonstrated efficient intracellular processing and DNA incorporation.
  • Significant tumor retention of radioactivity and regression of neuroblastoma xenografts were observed.
  • Radiotoxicity was directly proportional to DNA uptake and exposure time.

Conclusions:

  • Novel theranostic guanidines effectively target neuroblastoma cells via norepinephrine transporter.
  • These agents are incorporated into the DNA of proliferating neuroblastoma cells, leading to radiotoxicity.
  • Preclinical studies demonstrate significant tumor regression, supporting their potential as a new therapeutic option for high-risk neuroblastoma.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.2K
DNA-only Transposons02:57

DNA-only Transposons

DNA-only transposons are called autonomous transposons since they code for the enzyme transposase that is required for the transposition mechanism. Insertion of transposons can alter gene functions in multiple ways. They can mutate the gene, alter gene expression by introducing a novel promoter or insulator sequence, introduce new splice sites, and change the mRNA transcripts produced, or remodel chromatin structure.
The donor site from where the transposon is excised is either degraded or...
17.3K
Regulated mRNA Transport02:22

Regulated mRNA Transport

In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.9K
Facilitated Transport01:19

Facilitated Transport

The chemical and physical properties of plasma membranes cause them to be selectively permeable. Since plasma membranes have both hydrophobic and hydrophilic regions, substances need to be able to transverse both regions. The hydrophobic area of membranes repels substances such as charged ions. Therefore, such substances need special membrane proteins to cross a membrane successfully. In  facilitated transport, also known as facilitated diffusion, molecules and ions travel across a...
146.6K